Quick answers
- What is Tiazac Extended Release?
- Tiazac Extended Release is a brand name of Diltiazem, a prescription medicine. The FDA NDC Directory lists 6 Tiazac Extended Release products in 6 strengths and forms.
- Who makes Tiazac Extended Release?
- Bausch holds the FDA application for Tiazac Extended Release (NDA020401, approved September 11, 1995).
- Is there a generic or store brand of Tiazac Extended Release?
- Yes. The FDA NDC Directory lists 150 other products with the same active ingredients, strength and form as a Tiazac Extended Release product, 150 of them generic. Ask your pharmacist whether one is right for you.
- Has Tiazac Extended Release been recalled?
- No recall linked to Tiazac Extended Release products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Tiazac Extended Release is
Each Tiazac Extended Release product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Diltiazem · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| diltiazem hydrochloride 120 mg capsule, extended release (oral) | Tiazac Extended Release | 46 products, 31 companies | DailyMed |
| diltiazem hydrochloride 180 mg capsule, extended release (oral) | Tiazac Extended Release | 34 products, 20 companies | DailyMed |
| diltiazem hydrochloride 240 mg capsule, extended release (oral) | Tiazac Extended Release | 31 products, 22 companies | DailyMed |
| diltiazem hydrochloride 300 mg capsule, extended release (oral) | Tiazac Extended Release | 19 products, 14 companies | DailyMed |
| diltiazem hydrochloride 360 mg capsule, extended release (oral) | Tiazac Extended Release | 17 products, 12 companies | DailyMed |
| diltiazem hydrochloride 420 mg capsule, extended release (oral) | Tiazac Extended Release | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Diltiazem →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA020401 | Bausch | September 11, 1995 | 6 |
Companies that list Tiazac Extended Release
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tiazac Extended Release products.
- Bausch Health US, LLC6 products
Recalls
No recall linked to Tiazac Extended Release products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.